[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343485-105":59,"doc-detail-343485-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","construction-and-validation-of-senescence-risk-score-signature-as-a-novel-biomarker-in-liver-hepatocellular-carcinoma-a-bioinformatic-analysis","Construction and validation of senescence risk score signature as a novel biomarker in liver hepatocellular carcinoma - a bioinformatic analysis","","Bioinformatic analyses were used to construct and validate a senescence risk score signature (SRSS) as a novel prognostic biomarker for liver hepatocellular carcinoma. Public datasets (GSE22405, GSE57957) and senescence-related genes were combined as a training set, while TCGA LIHC and PAAD samples served for validation. Differentially expressed senescence-related genes were screened using univariate/multivariate Cox regression and enrichment analyses. A three-gene LASSO model assessed overall survival with Kaplan-Meier and ROC, with risk scores supported by nomograms and decision curve analysis, highlighting stronger prognostic performance than clinical factors.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/construction-and-validation-of-senescence-risk-score-signature-as-a-novel-biomarker-in-liver-hepatocellular-carcinoma-a-bioinformatic-analysis/343485/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/construction-and-validation-of-senescence-risk-score-signature-as-a-novel-biomarker-in-liver-hepatocellular-carcinoma-a-bioinformatic-analysis/343485.png","ImageObject",300,407,{"name":92,"@type":93},"River Wang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the senescence risk score signature (SRSS) in this study?","Question",{"text":112,"@type":113},"SRSS is a prognostic model built from senescence-related genes to estimate survival risk in liver hepatocellular carcinoma patients.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which datasets and gene inputs were used to construct and validate the model?",{"text":117,"@type":113},"The study used GSE22405 and GSE57957 with senescence-related genes for training, and TCGA LIHC and PAAD for validation.",{"name":119,"@type":110,"acceptedAnswer":120},"How was the SRSS model evaluated for prognostic performance?",{"text":121,"@type":113},"Overall survival and survival rates were assessed using Kaplan-Meier curves and ROC curves, and predictive value was further examined with risk scores, nomograms, decision curve analysis, and clinical information.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},343485,1790163933,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","Construction and validation of senescence risk score signature as a novel biomarker in liver hepatocellular carcinoma:  \na bioinformatic analysis  \nTianqi Lai1,2^, Feilong Li1, Leyang Xiang1, Zhilong Liu1, Qiang Li1, Mingrong Cao1, Jian Sun1, Youzhu Hu1,3, Tongzheng Liu4, Junjie Liang1  \n1Department of Hepatobiliary Surgery, The First Affiliated Hospital, Jinan University, Guangzhou, China; 2Department of Clinical Medicine, Medical College, Jinan University, Guangzhou, China; 3Department of General Surgery, The Affiliated Shunde Hospital, Jinan University, Foshan, China; 4College of Pharmacy/International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Ministry of Education (MOE) of China, Jinan University, Guangzhou, China  \nContributions: (I) Conception and design: T Lai, J Liang; (II) Administrative support: Y Hu, T Liu, J Liang; (III) Provision of study materials or patients: J Sun, Y Hu, T Liu; (IV) Collection and assembly of data: T Lai, F Li, L Xiang; (V) Data analysis and interpretation: Z Liu, Q Li, M Cao;  \n(VI) Manuscript writing: All authors; (VII) Final approval of manuscript: All authors.  \nCorrespondence to: Youzhu Hu, MD. Department of Hepatobiliary Surgery, The First Affiliated Hospital, Jinan University, 613 West Huangpu Avenue, Guangzhou 510630, China; Department of General Surgery, The Affiliated Shunde Hospital, Jinan University, Foshan, China. Email: drhyz@hotmail.com; Tongzheng Liu, PhD. College of Pharmacy/International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Ministry of Education (MOE) of China, Jinan University, 601 West Huangpu Avenue, Guangzhou 510632, China. Email: [liutongzheng@jnu.edu.cn](liutongzheng@jnu.edu.cn); Junjie Liang, MD. Department of Hepatobiliary Surgery, The First Affiliated Hospital, Jinan University, 613 West Huangpu Avenue, Guangzhou 510630, [China. Email: jjliang@jnu.edu.cn](China. Email: jjliang@jnu.edu.cn).  \nBackground: Globally, liver cancer as one of the most frequent fatal malignancies, hits hard and fast.  \nAnd the lack of effective treatments for liver hepatocellular carcinoma (LIHC), activates the researchers to promote promising precision medicine. Interestingly, emerging evidence proves that cellular senescenceis involved in the progression of cancers and is recognized for its hallmark-promoting capabilities. Hence, efforts have been made to construct and validate the senescence risk score signature (SRSS) model as a novel  \nprognostic biomarker for LIHC.  \nMethods: The existing databases were mined for the following bioinformatics analyses. GSE22405, GSE57957, and senescence-related genes (SRGs) from public databases were utilized as a training set and the validation set was constituted by LIHC and pancreatic adenocarcinoma (PAAD) from The Cancer Genome Atlas (TCGA) . After overlapping differentially expressed genes (DEGs) with SRGs, differentially expressed SRGs were identified with the progression of liver cancer through univariate and multivariate Cox regression and enrichment analyses. The model that utilized three SRGs was constructed using the least absolute shrinkage and selection operator (LASSO) regression algorithm. Next, to evaluate the predictive performance of the SRSS model, the overall survival (OS) and survival rates were assessed through KaplanMeier (KM) and the receiver operating characteristic (ROC) curves. The predictive value for LIHC prognosis was further evaluated by capitalizing on risk score, nomograms, decision curve analysis (DCA)  \ncurves, and clinical information including tumor stages, gender, age, and race.  \nResults: DEGs were revealed as enriching in multiple tumor-related biological processes (BPs) and pathways. IGFBP3, SOCS2, and RACGAP1 were identified as the three considerable SRGs for the model.  \nThe high-risk group had a worse prognosis [both hazard ratio (HR) >1, P\u003C0.001] and ROC curves showed a reliable pred","cbCaikRoY5xOxMo3","https://ap.wps.com/l/cbCaikRoY5xOxMo3","pdf",925789,14,"English","# Introduction\n## Background\n# Methods\n## Training and validation datasets\n## Cox regression, LASSO, and model evaluation\n# Results\n## Differentially expressed senescence-related genes\n## Prognostic performance and model comparison\n# Conclusions\n# Keywords","[{\"question\":\"What is the senescence risk score signature (SRSS) in this study?\",\"answer\":\"SRSS is a prognostic model built from senescence-related genes to estimate survival risk in liver hepatocellular carcinoma patients.\"},{\"question\":\"Which datasets and gene inputs were used to construct and validate the model?\",\"answer\":\"The study used GSE22405 and GSE57957 with senescence-related genes for training, and TCGA LIHC and PAAD for validation.\"},{\"question\":\"How was the SRSS model evaluated for prognostic performance?\",\"answer\":\"Overall survival and survival rates were assessed using Kaplan-Meier curves and ROC curves, and predictive value was further examined with risk scores, nomograms, decision curve analysis, and clinical information.\"}]","Construction and validation of senescence risk score signature as a novel biomarker in liver hepatocellular carcinoma - a bioinformatic analysis | PDF",1790051291,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c02315e70ab8b025fed95c60e1ac5228.webp",983,1287,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/af5324afd87a6e47edcdfe4c6a9d94e6.webp",982,1286,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f444ce5b92bef30d8f0b67f460d08ec0.webp",981,1284,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/48dd21af34c94d3f6614d7085bfb534e.webp",980,1283]